- Home
- EGY vs PSNL Comparison
EGY vs PSNL Comparison
Compare EGY & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EGY
- PSNL
- Stock Information
- Founded
- EGY 1985
- PSNL 2011
- Country
- EGY United States
- PSNL United States
- Employees
- EGY N/A
- PSNL N/A
- Industry
- EGY Oil & Gas Production
- PSNL Medical Specialities
- Sector
- EGY Energy
- PSNL Health Care
- Exchange
- EGY Nasdaq
- PSNL Nasdaq
- Market Cap
- EGY 493.4M
- PSNL 460.7M
- IPO Year
- EGY N/A
- PSNL 2019
- Fundamental
- Price
- EGY $4.53
- PSNL $4.89
- Analyst Decision
- EGY Strong Buy
- PSNL Strong Buy
- Analyst Count
- EGY 1
- PSNL 4
- Target Price
- EGY $8.00
- PSNL $8.56
- AVG Volume (30 Days)
- EGY 1.0M
- PSNL 1.5M
- Earning Date
- EGY 03-12-2025
- PSNL 02-26-2025
- Dividend Yield
- EGY 5.52%
- PSNL N/A
- EPS Growth
- EGY 170.05
- PSNL N/A
- EPS
- EGY 0.86
- PSNL N/A
- Revenue
- EGY $506,421,000.00
- PSNL $87,489,000.00
- Revenue This Year
- EGY $9.05
- PSNL $15.76
- Revenue Next Year
- EGY N/A
- PSNL $4.90
- P/E Ratio
- EGY $5.25
- PSNL N/A
- Revenue Growth
- EGY 25.82
- PSNL 24.05
- 52 Week Low
- EGY $4.03
- PSNL $1.12
- 52 Week High
- EGY $7.51
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- EGY 46.32
- PSNL 45.39
- Support Level
- EGY $4.53
- PSNL $5.22
- Resistance Level
- EGY $4.82
- PSNL $5.50
- Average True Range (ATR)
- EGY 0.15
- PSNL 0.57
- MACD
- EGY 0.06
- PSNL -0.18
- Stochastic Oscillator
- EGY 56.72
- PSNL 8.33
About EGY VAALCO Energy Inc.
VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea and Corporate and Other. The company generates maximum revenue from the Gabon segment.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.